C-MER Medical Holdings Limited (HKG:3309)
Hong Kong · Delayed Price · Currency is HKD 1.270
+0.020 (1.60%)
Apr 24, 2026, 3:56 PM HKT
C-MER Medical Holdings Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 100.37 | -135.16 | 62 | -21.88 | 21.86 |
Depreciation & Amortization | 198.76 | 213.62 | 220.99 | 224.03 | 148.58 |
Loss (Gain) From Sale of Assets | -2.38 | 1.43 | 0.12 | 0.43 | 5.12 |
Asset Writedown & Restructuring Costs | 3.17 | 199.98 | 2.5 | - | - |
Loss (Gain) From Sale of Investments | -11.65 | -3.44 | 10.74 | 33.22 | -16.71 |
Loss (Gain) on Equity Investments | 0.58 | 0.98 | -3.16 | -37.8 | -10.65 |
Stock-Based Compensation | 1.24 | 0.35 | 0.27 | 1.33 | 4.26 |
Other Operating Activities | 23.55 | 16.24 | 16.72 | -1.75 | -0.63 |
Change in Accounts Receivable | -5.65 | -5.52 | -6.53 | -26.7 | -18.54 |
Change in Inventory | 0.01 | -8.43 | 11.87 | -8.66 | -9.21 |
Change in Accounts Payable | -8.24 | 1.97 | 10.57 | 0.89 | 19.75 |
Change in Unearned Revenue | 4.08 | 4.9 | 15.67 | 30.18 | 1.98 |
Change in Other Net Operating Assets | -20.55 | -3.79 | 19.4 | -28.44 | -1.39 |
Operating Cash Flow | 283.29 | 283.12 | 361.15 | 164.86 | 144.4 |
Operating Cash Flow Growth | 0.06% | -21.61% | 119.06% | 14.17% | 31.76% |
Capital Expenditures | -77.52 | -158.62 | -115.49 | -89.01 | -118.14 |
Sale of Property, Plant & Equipment | 3.67 | 3.26 | 14.52 | 1.26 | 0.01 |
Cash Acquisitions | -17.85 | -1.4 | - | -94.33 | -236.67 |
Divestitures | - | - | - | - | 5.69 |
Sale (Purchase) of Intangibles | -3.43 | -0.77 | -0.37 | -2.22 | -11.09 |
Sale (Purchase) of Real Estate | - | -99.95 | - | - | - |
Investment in Securities | -68.53 | 40.08 | -11.03 | -39.16 | -40 |
Other Investing Activities | 21.07 | 42.68 | -133 | 27.76 | 4.48 |
Investing Cash Flow | -142.59 | -174.72 | -245.37 | -195.7 | -395.73 |
Short-Term Debt Issued | 234.93 | 258.27 | 10.78 | 31.26 | 181.11 |
Long-Term Debt Issued | - | - | - | 13.8 | 7.49 |
Total Debt Issued | 234.93 | 258.27 | 10.78 | 45.06 | 188.6 |
Short-Term Debt Repaid | -221.38 | -230.84 | -43.28 | -193.24 | -0.66 |
Long-Term Debt Repaid | -131.73 | -116.94 | -132.09 | -115.44 | -76.1 |
Total Debt Repaid | -353.1 | -347.79 | -175.37 | -308.68 | -76.76 |
Net Debt Issued (Repaid) | -118.17 | -89.52 | -164.59 | -263.62 | 111.84 |
Issuance of Common Stock | - | - | - | 607.66 | 9.25 |
Repurchase of Common Stock | -54.15 | -59.14 | -58.29 | -29.93 | - |
Common Dividends Paid | -28.88 | -2.36 | - | - | -22.97 |
Other Financing Activities | -20.08 | -43.9 | -20 | -20.44 | -13 |
Financing Cash Flow | -221.28 | -194.92 | -242.88 | 293.68 | 85.12 |
Foreign Exchange Rate Adjustments | 5.36 | -3.17 | -4.84 | -4.81 | -1.07 |
Net Cash Flow | -75.21 | -89.68 | -131.94 | 258.04 | -167.28 |
Free Cash Flow | 205.77 | 124.51 | 245.67 | 75.86 | 26.26 |
Free Cash Flow Growth | 65.27% | -49.32% | 223.85% | 188.91% | -66.38% |
Free Cash Flow Margin | 10.57% | 6.51% | 12.77% | 4.38% | 2.36% |
Free Cash Flow Per Share | 0.17 | 0.10 | 0.20 | 0.06 | 0.02 |
Cash Interest Paid | 2.84 | 0.81 | 17.02 | 19.24 | 13 |
Cash Income Tax Paid | 27.08 | 49.2 | 32.55 | 24.94 | 13.72 |
Levered Free Cash Flow | 187 | 107.98 | 64.56 | 503.17 | -168.04 |
Unlevered Free Cash Flow | 202.22 | 122.76 | 75.88 | 515.46 | -159.91 |
Change in Working Capital | -30.34 | -10.87 | 50.98 | -32.73 | -7.42 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.